J&J Consumer Health Sees Pandemic Accelerate Shift To Digital
J&J Consumer Health's worldwide chairman Thibaut Mongon told the recent Barclays Consumer Staples conference that COVID-19 had accelerated the shift to digital and what consumers expect from OTC brands.
You may also be interested in...
In first of what could be similar April-June earnings results from major consumer health firms, J&J reports 9.2% operational growth to $3.74bn in sales. Worldwide consumer health chief Thibaut Mongon touts segment’s results and outlook but says similar growth in second half isn’t assured.
J&J's senior director of medical affairs, EAME, Mark Watt, makes the case for the untapped potential of personalization through apps such as the company's Nicorette QuickMist SmartTrack product in this exclusive interview with HBW Insight.
Listerine mouthwash drove J&J’s oral care sales up 11.4% in the fourth quarter. Tylenol for adults was the star of its OTC drug business but weakness of children’s Tylenol products and other OTCs led to flat sales.